Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
| Cat.No. | Product Name | Price |
|---|---|---|
| CSC-DC010293 | Panoply™ Human NEK7 Knockdown Stable Cell Line | Inquiry |
| CSC-SC010293 | Panoply™ Human NEK7 Over-expressing Stable Cell Line | Inquiry |
| CSC-RT0817 | Human NEK7 Knockout Cell Line-HeLa | Inquiry |
| CLOE-0871 | Human NEK7 Insect Cell Lysate | Inquiry |
| CLKO-0320 | NEK7 KO Cell Lysate-HeLa | Inquiry |
| Cat.No. | Product Name | Price |
|---|---|---|
| AD10691Z | Human Nek7 adenoviral particles | Inquiry |
| LV19391L | human NEK7 (NM_133494) lentivirus particles | Inquiry |
| Cat.No. | Product Name | Price |
|---|---|---|
| SHH351284 | shRNA set against Human Nek7 (NM_133494.2) | Inquiry |
| SHH351288 | shRNA set against Mouse Nek7 (NM_021605.3) | Inquiry |
| SHH351292 | shRNA set against Rat Nek7 (NM_001108346.2) | Inquiry |
| SHW001864 | shRNA set against Chicken NEK7 (NM_001031264) | Inquiry |
| SHW006929 | shRNA set against Danio rerio NEK7 (NM_001003617) | Inquiry |
| Cat.No. | Product Name | Price |
|---|---|---|
| CDCL185457 | Human NEK7 ORF clone(NM_133494.2) | Inquiry |
| CDFR007981 | Rat Nek7 cDNA Clone(NM_001108346.2) | Inquiry |
| MiUTR1M-07594 | NEK7 miRNA 3'UTR clone | Inquiry |
| MiUTR4H-TG11831 | NEK7 miRNA 3'UTR clone | Inquiry |
| SKO0186 | NEK7 Validated sgRNA vector | Inquiry |
| CDCB163339 | Chicken NEK7 ORF Clone (NM_001031264) | Inquiry |
| CDCB168404 | Danio rerio NEK7 ORF Clone (NM_001003617) | Inquiry |
| CDCB194707 | Rabbit NEK7 ORF clone (XM_008268699.1) | Inquiry |
| CDCL137625 | Human Nek7 ORF clone (NM_021605.3) | Inquiry |
| CDCR374850 | Rat Nek7 ORF Clone(NM_001108346.2) | Inquiry |
| Cat.No. | Product Name | Price |
|---|---|---|
| CC-936 | NEK7 Easy KO Kit | Inquiry |
NIMA-related kinase 7, Nek7, is an important part of the activation of NLRP3 inflammatory bodies. Nek7 is widely present in eukaryotic cells and is one of the smallest members found in the NEK family. Nek7, located at both levels of the spindle, consists almost entirely of catalytic kinase domains with two amino-terminal kinase regions and no carboxy terminus. Nek6 and Nek7 have the same catalytic domain of 85%. The mitotic regulatory factor Polo-like kinase 1 (Plk1) and cyclin dependent kinase 1 (CDK1) activate Nek9, making it directly Combine Nek6 and Nek7 to control cytokinesis.
On the other hand, Nek7 is involved in the activation of NLRP3 inflammatory bodies as part of the NLRP3 inflammatory complex. Inactive NLRP3 inflammatory bodies are induced by the NF-κB pathway, and under the coordination of ROS pathway, K+ efflux, lysosomal disruption and Nek7, the inactive NLRP3 inflammatory body aggregates and activates, eventually leading to IL -1β, IL-18 maturation and secretion. By blocking the secretion of IL1β, IL-18 and binding to its receptor, it is possible to control and alleviate the progression of inflammatory diseases. Therefore, Nek7 may become a new target for the treatment of various inflammatory diseases.
Figure 1. Nek7 interacts and stabilizes TRF1 at telomeres upon oxidative damage. (Tan, R., et al. 2017)
Nek7 and Mitosis
Located in the centrosome, Nek7 is one of the 11 NEK kinases found in vertebrates and is one of the smallest members of the conserved non-mitosis Aspergillus (NIMA)-related family members. It is widely expressed in various tissues such as brain, heart, lung, liver, spleen and kidney. As a multi-functional protein kinase, Nek7 regulates proteins involved in biological processes. It is a highly conserved serine/threonine kinase (Nek) essential for mammalian survival, cellular changes, and mitosis. The role of the mitotic kinase Nek in cell mitosis is similar to that of NIMA. The regulation of key members of the N2 family members involved in G2/M phase during mitosis promotes centrosome maturation and affects chromatin concentration and spindle formation.
Nek7 Involved in the Activation of NLRP3 Inflammatory Bodies
Under normal growth conditions, Nek7 is in a low activity state, which is the key to maintaining the stability of the internal environment. However, in the pathological state, the homeostasis is destroyed, Nek7 is overexpressed, and multinucleated cells and apoptotic cells closely related to inflammation are produced in large quantities, eventually leading to the occurrence of inflammatory reactions in the body. Studies have shown that Nek7 is an important regulatory substance required for the activation of NLRP3 inflammatory bodies. In the downstream reaction of NLRP3 activation, Nek7 binds to the leucine rich repeat (LRR) in NLRP3 in an independent kinase manner, thereby further mediating the activation of NLRP3 inflammatory bodies, which cause an inflammatory response. Experiments have shown that Nek7 has a key function of reducing the dynamic stability of microtubules during the in vitro interval and phosphorylation of α-tubulin and β-tubulin, with microtubule acetylation and NLRP3 inflammatory body signaling. In the same way, in the cells knocked out of Nek7, alpha-tubulin acetylation increased, indicating that Nek7 is involved in microtubule acetylation during activation of NLRP3 inflammatory bodies.
References: